Dana Lueck-Mammen

The shares are listed on the Nasdaq Global Select Market

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Zynga Inc. of $874.5 million aggregate principal amount of its 0%…

Davis Polk advised the joint book-running managers in connection with a $460 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…

Davis Polk advised the initial purchaser in connection with a Rule 144A offering by Bloom Energy Corporation of $200 million aggregate principal amount of its 2.500% green convertible…

Davis Polk advised the representatives of the several underwriters in connection with a debut SEC-registered bond offering by ServiceNow, Inc. of $1.5 billion aggregate principal amount of…

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Turning Point Therapeutics, Inc. of its common stock for up to an aggregate amount of $250 million…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by NetApp, Inc. of $750 million aggregate principal amount of its 1.875%…

Davis Polk advised Credo Technology Group Holding Ltd on its private placement of approximately $100 million in shares of its Series D preferred stock. Credo is a leading provider of high…

Davis Polk advised the representatives of the several initial purchasers in connection with a Rule 144A offering by Palo Alto Networks, Inc. of an aggregate principal amount of $2…

Davis Polk advised the joint book-running managers in connection with a $325 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…